The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glycated Albumin-Global Market Insights and Sales Trends 2025
Synopsis
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin market size is expected to reach US$ 602 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Albumin in various end use industries. The expanding demands from the Hospitals and Clinics and Laboratories, are propelling Glycated Albumin market. Glycated Albumin (Human), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glycated Albumin (Animal) segment is estimated at % CAGR for the next seven-year period.
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Albumin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Albumin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Albumin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Albumin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Albumin covered in this report include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura and Leadman, etc.
The global Glycated Albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Global Glycated Albumin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Albumin market, Segment by Type:
Glycated Albumin (Human)
Glycated Albumin (Animal)
Global Glycated Albumin market, by Application
Hospitals and Clinics
Laboratories
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glycated Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Diabetes afflicts an increasing number of people worldwide each year. Proper blood glucose control is essential in preventing complications associated with diabetes, such as neuropathy, nephropathy and retinopathy.
Glycation is the result of a sugar molecule, such as fructose or glucose, bonding to a protein or lipid molecule without the controlling action of an enzyme. It is a haphazard process that impairs the functioning of biomolecules. The high levels of glucose present in diabetes meatus results in increased glycation of all proteins, including, albumin. Measurement of the amount of the glycation reaction resulting from the combination of glucose with free amino groups in proteins present in the blood is used to monitor the level of glucose that has generally been present in body fluids over a preceding period.
Thus serum glycated albumin assay can be used to determine the current level of glycation of albumin, the most abundant plasma protein. Hence, the gycated albumin assay may be used as a marker of glycemic control in diabetes and reflects glycemic control over the precious 2 to 4 weeks.
The global Glycated Albumin market size is expected to reach US$ 602 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Glycated Albumin in various end use industries. The expanding demands from the Hospitals and Clinics and Laboratories, are propelling Glycated Albumin market. Glycated Albumin (Human), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glycated Albumin (Animal) segment is estimated at % CAGR for the next seven-year period.
The major players in global Glycated Albumin market include Asahi Kasei Pharma, DIAZYME, Abnova, etc. The top 3 players occupy about 85% shares of the global market. Asia-Pacific and Europe are main markets, they occupy about 60% of the global market. Glycated Albumin (Animal) is the main type, with a share about 60%. Hospitals and Clinics is the main application, which holds a share about 50%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycated Albumin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycated Albumin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycated Albumin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycated Albumin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycated Albumin covered in this report include Asahi Kasei Pharma, DIAZYME, Abnova, LifeSpan, Exocell, BSBE, Medicalsystem, Maccura and Leadman, etc.
The global Glycated Albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei Pharma
DIAZYME
Abnova
LifeSpan
Exocell
BSBE
Medicalsystem
Maccura
Leadman
Simes Sikma
NINGBO PUREBIO
Global Glycated Albumin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycated Albumin market, Segment by Type:
Glycated Albumin (Human)
Glycated Albumin (Animal)
Global Glycated Albumin market, by Application
Hospitals and Clinics
Laboratories
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Glycated Albumin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Glycated Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Glycated Albumin Market Overview
1.1 Glycated Albumin Product Overview
1.2 Glycated Albumin Market Segment by Type
1.2.1 Glycated Albumin (Human)
1.2.2 Glycated Albumin (Animal)
1.3 Global Glycated Albumin Market Size by Type
1.3.1 Global Glycated Albumin Market Size Overview by Type (2018-2029)
1.3.2 Global Glycated Albumin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Glycated Albumin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glycated Albumin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Glycated Albumin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Glycated Albumin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Glycated Albumin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Glycated Albumin Sales Breakdown by Type (2018-2023)
2 Global Glycated Albumin Market Competition by Company
2.1 Global Top Players by Glycated Albumin Sales (2018-2023)
2.2 Global Top Players by Glycated Albumin Revenue (2018-2023)
2.3 Global Top Players by Glycated Albumin Price (2018-2023)
2.4 Global Top Manufacturers Glycated Albumin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glycated Albumin Market Competitive Situation and Trends
2.5.1 Glycated Albumin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Glycated Albumin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glycated Albumin as of 2022)
2.7 Date of Key Manufacturers Enter into Glycated Albumin Market
2.8 Key Manufacturers Glycated Albumin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glycated Albumin Status and Outlook by Region
3.1 Global Glycated Albumin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Glycated Albumin Historic Market Size by Region
3.2.1 Global Glycated Albumin Sales in Volume by Region (2018-2023)
3.2.2 Global Glycated Albumin Sales in Value by Region (2018-2023)
3.2.3 Global Glycated Albumin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Glycated Albumin Forecasted Market Size by Region
3.3.1 Global Glycated Albumin Sales in Volume by Region (2024-2029)
3.3.2 Global Glycated Albumin Sales in Value by Region (2024-2029)
3.3.3 Global Glycated Albumin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Glycated Albumin by Application
4.1 Glycated Albumin Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Laboratories
4.2 Global Glycated Albumin Market Size by Application
4.2.1 Global Glycated Albumin Market Size Overview by Application (2018-2029)
4.2.2 Global Glycated Albumin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Glycated Albumin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glycated Albumin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Glycated Albumin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Glycated Albumin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Glycated Albumin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Glycated Albumin Sales Breakdown by Application (2018-2023)
5 North America Glycated Albumin by Country
5.1 North America Glycated Albumin Historic Market Size by Country
5.1.1 North America Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Glycated Albumin Sales in Volume by Country (2018-2023)
5.1.3 North America Glycated Albumin Sales in Value by Country (2018-2023)
5.2 North America Glycated Albumin Forecasted Market Size by Country
5.2.1 North America Glycated Albumin Sales in Volume by Country (2024-2029)
5.2.2 North America Glycated Albumin Sales in Value by Country (2024-2029)
6 Europe Glycated Albumin by Country
6.1 Europe Glycated Albumin Historic Market Size by Country
6.1.1 Europe Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Glycated Albumin Sales in Volume by Country (2018-2023)
6.1.3 Europe Glycated Albumin Sales in Value by Country (2018-2023)
6.2 Europe Glycated Albumin Forecasted Market Size by Country
6.2.1 Europe Glycated Albumin Sales in Volume by Country (2024-2029)
6.2.2 Europe Glycated Albumin Sales in Value by Country (2024-2029)
7 Asia-Pacific Glycated Albumin by Region
7.1 Asia-Pacific Glycated Albumin Historic Market Size by Region
7.1.1 Asia-Pacific Glycated Albumin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Glycated Albumin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Glycated Albumin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Glycated Albumin Forecasted Market Size by Region
7.2.1 Asia-Pacific Glycated Albumin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Glycated Albumin Sales in Value by Region (2024-2029)
8 Latin America Glycated Albumin by Country
8.1 Latin America Glycated Albumin Historic Market Size by Country
8.1.1 Latin America Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Glycated Albumin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Glycated Albumin Sales in Value by Country (2018-2023)
8.2 Latin America Glycated Albumin Forecasted Market Size by Country
8.2.1 Latin America Glycated Albumin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Glycated Albumin Sales in Value by Country (2024-2029)
9 Middle East and Africa Glycated Albumin by Country
9.1 Middle East and Africa Glycated Albumin Historic Market Size by Country
9.1.1 Middle East and Africa Glycated Albumin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Glycated Albumin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Glycated Albumin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Glycated Albumin Forecasted Market Size by Country
9.2.1 Middle East and Africa Glycated Albumin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Glycated Albumin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Asahi Kasei Pharma
10.1.1 Asahi Kasei Pharma Company Information
10.1.2 Asahi Kasei Pharma Introduction and Business Overview
10.1.3 Asahi Kasei Pharma Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Asahi Kasei Pharma Glycated Albumin Products Offered
10.1.5 Asahi Kasei Pharma Recent Development
10.2 DIAZYME
10.2.1 DIAZYME Company Information
10.2.2 DIAZYME Introduction and Business Overview
10.2.3 DIAZYME Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 DIAZYME Glycated Albumin Products Offered
10.2.5 DIAZYME Recent Development
10.3 Abnova
10.3.1 Abnova Company Information
10.3.2 Abnova Introduction and Business Overview
10.3.3 Abnova Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abnova Glycated Albumin Products Offered
10.3.5 Abnova Recent Development
10.4 LifeSpan
10.4.1 LifeSpan Company Information
10.4.2 LifeSpan Introduction and Business Overview
10.4.3 LifeSpan Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LifeSpan Glycated Albumin Products Offered
10.4.5 LifeSpan Recent Development
10.5 Exocell
10.5.1 Exocell Company Information
10.5.2 Exocell Introduction and Business Overview
10.5.3 Exocell Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Exocell Glycated Albumin Products Offered
10.5.5 Exocell Recent Development
10.6 BSBE
10.6.1 BSBE Company Information
10.6.2 BSBE Introduction and Business Overview
10.6.3 BSBE Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 BSBE Glycated Albumin Products Offered
10.6.5 BSBE Recent Development
10.7 Medicalsystem
10.7.1 Medicalsystem Company Information
10.7.2 Medicalsystem Introduction and Business Overview
10.7.3 Medicalsystem Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Medicalsystem Glycated Albumin Products Offered
10.7.5 Medicalsystem Recent Development
10.8 Maccura
10.8.1 Maccura Company Information
10.8.2 Maccura Introduction and Business Overview
10.8.3 Maccura Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Maccura Glycated Albumin Products Offered
10.8.5 Maccura Recent Development
10.9 Leadman
10.9.1 Leadman Company Information
10.9.2 Leadman Introduction and Business Overview
10.9.3 Leadman Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Leadman Glycated Albumin Products Offered
10.9.5 Leadman Recent Development
10.10 Simes Sikma
10.10.1 Simes Sikma Company Information
10.10.2 Simes Sikma Introduction and Business Overview
10.10.3 Simes Sikma Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Simes Sikma Glycated Albumin Products Offered
10.10.5 Simes Sikma Recent Development
10.11 NINGBO PUREBIO
10.11.1 NINGBO PUREBIO Company Information
10.11.2 NINGBO PUREBIO Introduction and Business Overview
10.11.3 NINGBO PUREBIO Glycated Albumin Sales, Revenue and Gross Margin (2018-2023)
10.11.4 NINGBO PUREBIO Glycated Albumin Products Offered
10.11.5 NINGBO PUREBIO Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glycated Albumin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glycated Albumin Industrial Chain Analysis
11.4 Glycated Albumin Market Dynamics
11.4.1 Glycated Albumin Industry Trends
11.4.2 Glycated Albumin Market Drivers
11.4.3 Glycated Albumin Market Challenges
11.4.4 Glycated Albumin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glycated Albumin Distributors
12.3 Glycated Albumin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
